Kinetics of Circulating Tumor DNA in Lymphoma Treated by Immuno-chemotherapy
Condition(s):Diffuse Large B Cell LymphomaLast Updated:November 21, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Diffuse Large B Cell LymphomaLast Updated:November 21, 2023Not yet recruiting
Condition(s):Primary Mediastinal Large B-cell LymphomaLast Updated:April 1, 2021Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:May 20, 2022Not yet recruiting
Condition(s):Metastatic Colorectal Cancer; Pancreas Adenocarcinoma; CholangiocarcinomaLast Updated:March 7, 2024Recruiting
Condition(s):Circulating Tumor DNA (ctDNA); Gastric CancerLast Updated:April 28, 2022Recruiting
Condition(s):Locally Advanced Rectal Carcinoma; Circulating Tumor DNALast Updated:November 1, 2022Recruiting
Condition(s):Esophageal Cancer; Gastric CancerLast Updated:October 6, 2020Recruiting
Condition(s):Soft Tissue SarcomaLast Updated:March 22, 2024Recruiting
Condition(s):Non-small Cell Lung Cancer MetastaticLast Updated:August 3, 2023Recruiting
Condition(s):Gastric Cancer; Circulating Tumor DNA (ctDNA)Last Updated:February 6, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.